Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee approves amendment allowing 92-day supply for injectable testosterone
Summary
The Senate Health and Human Services Committee voted to amend House Bill 126 to allow injectable androgen prescriptions for chronic low testosterone to be filled for up to a 92-day supply, matching an existing allowance for topical formulations.
Chair Rocheford, chair of the Senate Health and Human Services Committee, moved and the committee approved an amendment to House Bill 126 to allow injectable androgen prescriptions for the treatment of chronic low testosterone to be filled for up to a 92-day supply, matching current law for topically applied androgen formulations.
The amendment, identified in the hearing as 2025-3020s, removes a proposed requirement that…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
